Discipline | SYN | WP | DIV | OWS | SW | HD | |
---|---|---|---|---|---|---|---|
Respondents | ALL | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
Responding athletes | 1244 (51.6) | 162 (47.8) | 316 (76.1) | 93 (37.5) | 71 (38.0) | 576 (48.2) | 26 (86.7) |
Country coverage | 78 (41.9%) | 21 (46.7) | 19 (95.0) | 19 (39.6) | 18 (35.3) | 73 (39.3) | 15 (93.8) |
Mean age | 22.1 | 20.9 | 24.8 | 21.8 | 22.8 | 21.3 | 30.9 |
Gender (male/female) | 1151/1262 | 10/329 | 208/207 | 137/111 | 107/80 | 669/525 | 20/10 |
Health complaints | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
Athletes with complaints | 324 (26.1) | 44 (27.2) | 85 (26.9) | 48 (51.6) | 15 (21.1) | 116 (20.1) | 16 (61.5) |
Injuries | 237 (19.1) | 33 (20.4) | 63 (19.9) | 46 (49.5) | 7 (9.9) | 73 (12.7) | 15 (57.7) |
Illnesses | 62 (5.0) | 8 (4.9) | 13 (4.1) | 1 (1.1) | 6 (8.5) | 34 (5.9) | 0 |
Injury and illness | 25 (2.0) | 3 (1.9) | 9 (2.9) | 1 (1.1) | 2 (2.8) | 9 (1.6) | 1 (3.9) |
Complaints of substantial severity | 132 (10.6) | 13 (8.0) | 40 (12.7) | 25 (26.9) | 2 (2.8) | 44 (7.6) | 8 (30.8) |
Complaints resulting in time-loss | 116 (9.3) | 13 (8.0) | 32 (10.1) | 21 (22.6) | 3 (4.2) | 38 (6.6) | 9 (34.6) |
Medication in the previous 4 weeks | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
Painkillers | 175 (14.1) | 26 (16.0) | 47 (14.9) | 27 (29.0) | 5 (7.0) | 60 (10.4) | 10 (38.5) |
Cortisone | 28 (2.3) | 4 (2.5) | 7 (2.2) | 7 (7.5) | 0 | 9 (1.6) | 1 (3.8) |
Muscle relaxants | 66 (5.3) | 10 (6.2) | 18 (5.7) | 12 (12.9) | 4 (5.6) | 19 (3.3) | 3 (11.5) |
Sleeping pills | 46 (3.7) | 5 (3.1) | 6 (1.9) | 5 (5.4) | 2 (2.8) | 24 (4.2) | 4 (15.4) |
Psychotropic drugs | 20 (1.6) | 2 (1.2) | 4 (1.3) | 1 (1.1) | 1 (1.4) | 11 (1.9) | 1 (3.8) |
ALL, All disciplines; DIV, diving; FINA, Fédération Internationale de Natation; HD, high diving; OWS, open water swimming; SW, swimming; SYN, synchronised swimming; WP, water polo.